• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • Eric Van Cutsem, Vladimir M. Moiseyenko, +9 authors Jaffer A. Ajani
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2006 (First Publication: 1 November 2006)
  • PURPOSE In the randomized, multinational phase II/III trial (V325) of untreated advanced gastric cancer patients, the phase II part selected docetaxel, cisplatin, and fluorouracil (DCF) overExpand
  • John S. Macdonald, Steven R Smalley, +8 authors James A. Martenson
  • Medicine
  • The New England journal of medicine
  • 2001 (First Publication: 1 June 2002)
  • BACKGROUND Surgical resection of adenocarcinoma of the stomach is curative in less than 40 percent of cases. We investigated the effect of surgery plus postoperative (adjuvant) chemoradiotherapy onExpand
  • Hansjochen Wilke, Kei Muro, +17 authors Atsushi Ohtsu
  • Medicine
  • The Lancet. Oncology
  • 2014 (First Publication: 1 October 2014)
  • BACKGROUND VEGFR-2 has a role in gastric cancer pathogenesis and progression. We assessed whether ramucirumab, a monoclonal antibody VEGFR-2 antagonist, in combination with paclitaxel would increaseExpand
  • Stephen R. Smalley, Jacqueline Benedetti, +10 authors John S. Macdonald
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2012 (First Publication: 1 July 2012)
  • PURPOSE Surgical resection of gastric cancer has produced suboptimal survival despite multiple randomized trials that used postoperative chemotherapy or more aggressive surgical procedures. WeExpand
  • Jaffer A. Ajani, W. Rodriguez, +7 authors S. Abreu Falcón
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2010 (First Publication: 20 March 2010)
  • PURPOSE Patients with advanced gastric or gastroesophageal adenocarcinoma need more efficacious and safer treatments than established today. S-1, a contemporary oral fluoropyrimidine, can provideExpand